Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:17 AM ET

No photo found yet (own website and image search run after this page is viewed)

Isaac Blech

Named as an officer, director or promoter on SEC Form D filings · NY, CA, MD, NJ, NC, IA, MA, PA, VA, FL · Jun 6, 2011 → Feb 7, 2019

20deals (issuers)

$767Mreported sold

2,970investors

75Form D filings

2011–2019years on file

Follow this person Look further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:23 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Isaac Blech is listed as an executive officer and director on 75 SEC Form D filings by 20 issuers between Jun 2011 and Jul 2019. Largest by amount reported sold: Avalo Therapeutics, Inc. (Rockville, MD — biotechnology — 2012–2017; $130.6M reported sold to 156 investors), Diffusion Pharmaceuticals Inc. (Charlottesville, VA — pharmaceuticals — 2014–2017; $85.7M reported sold to 181 investors), Centrexion Therapeutics Corp (Boston, MA — biotechnology — 2013–2018; $69.6M reported sold to 124 investors), X-Vax Technology, Inc. (Jupiter, FL — biotechnology — 2016–2019; $56.5M reported sold to 306 investors), Edge Therapeutics, Inc. (Berkeley Heights, NJ — pharmaceuticals — 2013–2015; $56M reported sold to 104 investors) and 15 more (all listed below).

What this means That is a lot of deals — 20 separate companies raised money with this person listed as executive officer and director, over about 8 years. Across those companies the filings report $767M sold in total.

Listed alongside Cary Sucoff (28 shared filings), Patrick Kolenik (22 shared filings), Sol J Barer (19 shared filings), John Catsimatidis (13 shared filings), Joseph Grano, Jr. (13 shared filings) and 197 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Isaac. Each name links to their own page.

The issuers belong to 3 sponsor groups: X4 Pharmaceuticals (2 issuers, $120M reported sold, 2010–2025), Elicio Therapeutics (2 issuers, $28M reported sold, 2012–2024) and Diffusion Pharmaceuticals (2 issuers, $3.15M reported sold, 2009–2020).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 17 court cases matching the name, 8 SEC releases, 1 state regulator order, 2 bankruptcy cases matching the name listed in Key records below.

What this means 28 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared the newest 50 of 75 public filings for Isaac Blech and found 16 differences, 5 worth asking the sponsor about: 4 regulator actions name the subject or team members; 5 court cases name Isaac Blech; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Isaac Blech has not run yet — it is joining a line of 50,801 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

17 cases: 6 closed (disposition not in docket feed), 5 dismissed, 6 judgment

Richard Blech v. Gregory L. Gantman closed

District Court, C.D. California · No. 8:18-cv-02086 · Filed Nov 21, 2018 · Closed Apr 21, 2021 · Nature of suit: Racketeer/Corrupt Organization · Cause: 18:1962 Racketeering (RICO) Act

Role of Richard Blech: Plaintiff · Outcome: Terminated 2021-04-21 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (richard); court in the person's filing state (CA)

Securities and Exchange Commisison v. Blech dismissed

District Court, S.D. New York · No. 1:12-cv-03703 · Filed May 9, 2012 · Closed Jun 20, 2013 · Nature of suit: 850 Securities/Commodities · Cause: 15:77 Securities Fraud

Role of Blech: Defendant · Outcome: Terminated 2013-06-20 — FJC Integrated Database disposition: Dismissed: settled Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); surname only in the caption; court in the person's filing state (NY)

Irving H. Picard v. Isaac Blech closed

District Court, S.D. New York · No. 1:12-cv-02353 · Filed Mar 29, 2012 · Closed Aug 4, 2014 · Nature of suit: 423 Bankruptcy withdrawal 28 USC 157

Role of Isaac Blech: Defendant · Outcome: Terminated 2014-08-04 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); first name matches; court in the person's filing state (NY)

Blech v. LHR Inc. dismissed

District Court, E.D. New York · No. 2:02-cv-01078 · Filed Feb 15, 2002 · Closed May 13, 2003 · Nature of suit: 890 Other statutory actions

Role of Blech: Plaintiff · Outcome: Terminated 2003-05-13 — FJC Integrated Database disposition: Dismissed: settled Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); surname only in the caption; court in the person's filing state (NY)

Kumar v. D Blech & Co Inc dismissed

District Court, N.D. Illinois · No. 1:98-cv-03083 · Filed May 19, 1998 · Closed Sep 11, 1998 · Nature of suit: 190 Other contract actions

Role of D Blech & Co Inc: Defendant · Outcome: Terminated 1998-09-11 — FJC Integrated Database disposition: Voluntarily dismissed Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (d); court in IL (not a filing state)

Horvitz v. D. Blech & Co. closed

District Court, S.D. Florida · No. 9:97-cv-08465 · Filed Jun 13, 1997 · Closed Oct 14, 1997

Role of D. Blech & Co.: Defendant · Outcome: Terminated 1997-10-14 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (d); court in the person's filing state (FL)

Steele v. D. Blech & Co. closed

District Court, S.D. Florida · No. 9:97-cv-08403 · Filed May 28, 1997 · Closed Apr 15, 1998 · Nature of suit: 890 Other statutory actions

Role of D. Blech & Co.: Defendant · Outcome: Terminated 1998-04-15 — FJC Integrated Database disposition: Stayed pending bankruptcy Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (d); court in the person's filing state (FL)

Novoplus, Inc. v. D. Blech & Company closed

District Court, S.D. Florida · No. 1:97-cv-01536 · Filed May 13, 1997 · Closed May 19, 1998

Role of D. Blech & Company: Defendant · Outcome: Terminated 1998-05-19 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (d); court in the person's filing state (FL)

D. Blech & Co., Inc. v. Michlin judgment

District Court, S.D. Florida · No. 9:96-cv-08399 · Filed Jun 12, 1996 · Closed Aug 30, 1996 · Nature of suit: 890 Other statutory actions

Role of D. Blech & Co., Inc.: Plaintiff · Outcome: Terminated 1996-08-30 — FJC Integrated Database disposition: Judgment on award of arbitrator; judgment for defendant Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (d); court in the person's filing state (FL)

Keough v. D. Blech & Company judgment

District Court, S.D. New York · No. 1:95-cv-07693 · Filed Sep 6, 1995 · Closed Dec 14, 1995 · Nature of suit: 890 Other statutory actions

Role of D. Blech & Company: Defendant · Outcome: Terminated 1995-12-14 — FJC Integrated Database disposition: Other; judgment for plaintiff Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (d); court in the person's filing state (NY)

Virtual Vision Inc v. D Blech & Co Inc dismissed

District Court, W.D. Washington · No. 2:95-cv-01082 · Filed Jul 13, 1995 · Closed Mar 12, 1996 · Nature of suit: 422 Bankruptcy appeals rule 28 USC 158

Role of D Blech & Co Inc: Defendant · Outcome: Terminated 1996-03-12 — FJC Integrated Database disposition: Dismissed: settled Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (d); court in WA (not a filing state)

One Atlanta Plaza v. D. Blech & Company closed

District Court, D. Massachusetts · No. 1:95-mc-10332 · Filed May 8, 1995 · Closed Jan 3, 2007

Role of D. Blech & Company: Defendant · Outcome: Terminated 2007-01-03 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (d); court in the person's filing state (MA)

CS First Boston Corp v. Blech judgment

District Court, S.D. New York · No. 1:95-cv-02889 · Filed Apr 25, 1995 · Closed Jul 15, 1996 · Nature of suit: 370 Other fraud

Role of Blech: Defendant · Outcome: Terminated 1996-07-15 — FJC Integrated Database disposition: Other; judgment for both plaintiff and defendant Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); surname only in the caption; court in the person's filing state (NY)

Lease Management Svc v. Blech judgment

District Court, N.D. California · No. 3:94-cv-04120 · Filed Nov 30, 1994 · Closed May 24, 1995 · Nature of suit: 190 Other contract actions

Role of Blech: Defendant · Outcome: Terminated 1995-05-24 — FJC Integrated Database disposition: Judgment on consent; judgment for plaintiff Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); surname only in the caption; court in the person's filing state (CA)

Guilford v. D. Blech & Company judgment

District Court, D. Maryland · No. 1:94-cv-03046 · Filed Nov 2, 1994 · Closed Nov 22, 1994 · Nature of suit: 190 Other contract actions

Role of D. Blech & Company: Defendant · Outcome: Terminated 1994-11-22 — FJC Integrated Database disposition: Judgment on consent; judgment for plaintiff Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (d); court in the person's filing state (MD)

Pharmaceuticals v. D. Blech & Co., Inc. dismissed

District Court, D. Maryland · No. 1:94-cv-03024 · Filed Oct 28, 1994 · Closed May 30, 1995 · Nature of suit: 190 Other contract actions

Role of D. Blech & Co., Inc.: Defendant · Outcome: Terminated 1995-05-30 — FJC Integrated Database disposition: Voluntarily dismissed Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (d); court in the person's filing state (MD)

Mays v. D. Blech & Company judgment

District Court, S.D. New York · No. 1:94-cv-07704 · Filed Oct 24, 1994 · Closed Oct 10, 2003 · Nature of suit: 850 Securities/Commodities · Cause: 15:78m(a) Securities Exchange Act

Role of D. Blech & Company: Defendant · Outcome: Terminated 2003-10-10 — FJC Integrated Database disposition: Other; judgment for both plaintiff and defendant Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (d); court in the person's filing state (NY)

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:23 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

8 SEC releases; 1 state regulator order

David Blech Administrative proceeding

SEC · Sep 20, 2013 · Parties as named in the release: David Blech Read the release ↗

same rare surname (4 people in Form D filings); different first name (david)

David Blech and Margaret Chassman Litigation release

SEC · May 10, 2012 · Parties as named in the release: David Blech and Margaret Chassman Read the release ↗

same rare surname (4 people in Form D filings); different first name (david)

Richard Jonathan Blech Administrative proceeding

SEC · Jan 31, 2011 · Parties as named in the release: Richard Jonathan Blech Read the release ↗

same rare surname (4 people in Form D filings); different first name (jonathan); the person's filing state is named in the release

Richard Jonathan Blech Administrative proceeding

SEC · Aug 11, 2010 · Parties as named in the release: Richard Jonathan Blech Read the release ↗

same rare surname (4 people in Form D filings); different first name (jonathan); the person's filing state is named in the release

David Blech, Alefheim Prodani and Richard Silverman Litigation release

SEC · Feb 6, 2002 · Parties as named in the release: David Blech, Alefheim Prodani and Richard Silverman Read the release ↗

same rare surname (4 people in Form D filings); different first name (david); the person's filing state is named in the release

Credit Bancorp, Ltd., Credit Bancorp, Inc. Richard Jonathan Blech, Thomas Michael Rittweger, and Douglas C. Brandon Litigation release

SEC · Sep 28, 2001 · Parties as named in the release: Credit Bancorp, Ltd., Credit Bancorp, Inc. Richard Jonathan Blech, Thomas Michael Rittweger, and Douglas C. Brandon Read the release ↗

same rare surname (4 people in Form D filings); different first name (jonathan)

David Blech Administrative proceeding

SEC · Dec 8, 2000 · Parties as named in the release: David Blech Read the release ↗

same rare surname (4 people in Form D filings); different first name (david)

Credit Bancorp, Ltd., Credit Bancorp, Inc., Richard J. Blech, Thomas M. Rittweger and Douglas C. Brandon Litigation release

SEC · Nov 17, 1999 · Parties as named in the release: Credit Bancorp, Ltd., Credit Bancorp, Inc., Richard J. Blech, Thomas M. Rittweger and Douglas C. Brandon Read the release ↗

same rare surname (4 people in Form D filings); different first name (richard); the person's filing state is named in the release

Individuals Barred Or Suspended FINRA · Financial Industry Regulatory Authority (FINRA)

Order date not stated in the index entry we read · Regulator: Financial Industry Regulatory Authority (FINRA) · Parties (regulator's caption): David A. Blech (Registered Principal, New York, New York)

As listed by the regulator: David A. Blech (Registered Principal, New York, New York) was fined $20,000 and barred from association with any NASD member in any capacity. The National Business Conduct Committee (NBCC) affirmed the sanctions following appeal of a New York District Business Conduct Committee (DBCC) decision. The sanctions were based on findings that Blech failed to respond to NASD requests for information. Order / docket ↗ Regulator's list ↗

same rare surname (4 people in Form D filings); different first name (david); nationwide regulator (FINRA) — the state is not a signal

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Isaac Blech..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

2 cases: 2 closed (disposition not in docket feed)

One Atlantic Plaza Associates v. D Blech & Company closed

United States Bankruptcy Court, S.D. Florida. · No. 95-80003 · Filed Apr 18, 1995 · Closed Jan 31, 1996

Role of D Blech & Company: Defendant · Outcome: Case closed 1996-01-31 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (d); court in the person's filing state (FL)

One Atlanta Plaza Associates v. D. Blech & Co. closed

United States Bankruptcy Court, N.D. Georgia · No. 94-06871 · Filed Dec 21, 1994 · Closed Mar 30, 1995

Role of D. Blech & Co.: Defendant · Outcome: Case closed 1995-03-30 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (4 people in Form D filings, 22 federal dockets); different first name (d); court in GA (not a filing state)

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:23 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

16 differences found between the filings for Isaac Blech — 5 worth asking about (compared the newest 50 of 75 filings on Oct 24, 2026; older filings not covered)

Worth asking · Nov 17, 1999 – Jan 31, 2011

4 regulator actions name the subject or team members

Regulator action: Richard Jonathan Blech (Jan 31, 2011) · Regulator action: Richard Jonathan Blech (Aug 11, 2010) · Regulator action: David Blech, Alefheim Prodani and Richard Silverman (Feb 6, 2002) · Regulator action: Credit Bancorp, Ltd., Credit Bancorp, Inc., Richard J. Blech, Thomas M. Rittweger and Douglas C. Brandon (Nov 17, 1999)

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

Richard Jonathan Blech ↗Richard Jonathan Blech ↗David Blech, Alefheim Prodani and Richard Silverman ↗Credit Bancorp, Ltd., Credit Bancorp, Inc., Richard J. Blech, Thomas M. Rittweger and Douglas C. Brandon ↗

Sources

Richard Jonathan Blech ↗ (Jan 31, 2011)
Richard Jonathan Blech ↗ (Aug 11, 2010)
David Blech, Alefheim Prodani and Richard Silverman ↗ (Feb 6, 2002)
Credit Bancorp, Ltd., Credit Bancorp, Inc., Richard J. Blech, Thomas M. Rittweger and Douglas C. Brandon ↗ (Nov 17, 1999)

Note · Aug 23, 2001 – Jun 7, 2024

5 bankruptcy cases name the subject or team members

Bankruptcy case: Elucida Oncology, Inc. and Pharmaceutics International, Inc. — filed Jun 7, 2024 · Bankruptcy case: WaveGuide Corporation — filed Jun 12, 2018 · Bankruptcy case: Joseph W Ramelli — filed Jul 15, 2013 · Bankruptcy case: Aicher v. Mitsubishi Motors Corporation — filed Dec 10, 2010 · Bankruptcy case: Chase Manhattan Bank Usa Na v. Lame — filed Aug 23, 2001

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, D. New Jersey ↗Elucida Oncology, Inc. — PartnerFacts page ↗Docket · United States Bankruptcy Court, D. Massachusetts ↗WaveGuide Corp — PartnerFacts page ↗

Sources

Docket · United States Bankruptcy Court, D. New Jersey ↗ (Jun 7, 2024)
Elucida Oncology, Inc. — PartnerFacts page ↗ (Aug 3, 2023)
Docket · United States Bankruptcy Court, D. Massachusetts ↗ (Jun 12, 2018)
WaveGuide Corp — PartnerFacts page ↗ (Jul 30, 2026)
Docket · United States Bankruptcy Court, S.D. California ↗ (Jul 15, 2013)
Joseph W. Ramelli — PartnerFacts page ↗
Docket · United States Bankruptcy Court, N.D. California ↗ (Dec 10, 2010)
Michael Aicher — PartnerFacts page ↗

Worth asking · Nov 30, 1994 – May 9, 2012

5 court cases name Isaac Blech — 4 as defendant

By role: defendant in 4, plaintiff in 1. Newest: "Securities and Exchange Commisison v. Blech" (District Court, S.D. New York, May 9, 2012); "Irving H. Picard v. Isaac Blech" (District Court, S.D. New York, Mar 29, 2012); "Blech v. LHR Inc." (District Court, E.D. New York, Feb 15, 2002). Some of these are name matches with a match estimate below 95% — check each docket.

What this means Several court cases name this subject. Some are routine business suits. Ask what each was about and how it ended.

Docket · Securities and Exchange Commisison v. Blech ↗Docket · Irving H. Picard v. Isaac Blech ↗Docket · Blech v. LHR Inc. ↗Docket · CS First Boston Corp v. Blech ↗

Sources

Docket · Securities and Exchange Commisison v. Blech ↗ (May 9, 2012)
Docket · Irving H. Picard v. Isaac Blech ↗ (Mar 29, 2012)
Docket · Blech v. LHR Inc. ↗ (Feb 15, 2002)
Docket · CS First Boston Corp v. Blech ↗ (Apr 25, 1995)
Docket · Lease Management Svc v. Blech ↗ (Nov 30, 1994)

Worth asking · Sep 8, 2016 – Dec 20, 2022

Isaac Blech appears on 3 deals that stopped filing before reaching their target

Aridis Pharmaceuticals, Inc. (last filing Dec 20, 2022; $15,216,241 sold of $40,000,000); Sapience Therapeutics, Inc. (last filing Jul 13, 2020; $8,010,876 sold of $30,000,000); Regenovation, Inc. (last filing Sep 8, 2016; $1,375,500 sold of $4,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Aridis Pharmaceuticals, Inc. — PartnerFacts page ↗Sapience Therapeutics, Inc. — PartnerFacts page ↗Regenovation, Inc. — PartnerFacts page ↗

Sources

Aridis Pharmaceuticals, Inc. — PartnerFacts page ↗ (Dec 20, 2022)
Sapience Therapeutics, Inc. — PartnerFacts page ↗ (Jul 13, 2020)
Regenovation, Inc. — PartnerFacts page ↗ (Sep 8, 2016)

Worth asking · Feb 14, 2018

Paid seller listed without a CRD number: Maxim Group LLC — Alveo Technologies Inc.

Maxim Group LLC is listed as receiving sales compensation on 1 filing (Feb 14, 2018) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Form D · Feb 14, 2018 ↗BrokerCheck search: Maxim Group LLC ↗Alveo Technologies Inc. — PartnerFacts page ↗

Sources

Form D · Feb 14, 2018 ↗ (Feb 14, 2018)
BrokerCheck search: Maxim Group LLC ↗
Alveo Technologies Inc. — PartnerFacts page ↗ (Mar 29, 2021)

Worth asking · Apr 29, 2014 – Feb 14, 2018

7 Form Ds were filed more than 15 days after the first sale

Form D filed 453 days after the first sale — Alveo Technologies Inc. · Form D filed 176 days after the first sale — Adhera Therapeutics, Inc. · Form D filed 400 days after the first sale — Regenovation, Inc. · Form D filed 17 days after the first sale — root9B Technologies, Inc. · Form D filed 27 days after the first sale — root9B Technologies, Inc. · and 2 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Feb 14, 2018 ↗Alveo Technologies Inc. — PartnerFacts page ↗Form D · Nov 28, 2017 ↗Adhera Therapeutics, Inc. — PartnerFacts page ↗

Sources

Form D · Feb 14, 2018 ↗ (Feb 14, 2018)
Alveo Technologies Inc. — PartnerFacts page ↗ (Mar 29, 2021)
Form D · Nov 28, 2017 ↗ (Nov 28, 2017)
Adhera Therapeutics, Inc. — PartnerFacts page ↗ (Feb 19, 2020)
Form D · Sep 8, 2016 ↗ (Sep 8, 2016)
Regenovation, Inc. — PartnerFacts page ↗ (Sep 8, 2016)
Form D · Sep 26, 2016 ↗ (Sep 26, 2016)
root9B Technologies, Inc. — PartnerFacts page ↗ (Sep 26, 2016)

Note · Feb 11, 2014 – Jul 18, 2019

24 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — X-Vax Technology, Inc. (latest filing Jul 18, 2019) · No amendment in the last 12 months on an offering that may still be open — Elucida Oncology, Inc. (latest filing Feb 7, 2019) · No amendment in the last 12 months on an offering that may still be open — Elicio Therapeutics, Inc. (latest filing Sep 14, 2018) · No amendment in the last 12 months on an offering that may still be open — Elicio Therapeutics, Inc. (latest filing Jun 5, 2018) · No amendment in the last 12 months on an offering that may still be open — Nacuity Pharmaceuticals, Inc. (latest filing Jul 20, 2017) · and 19 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D/A · Jul 18, 2019 ↗X-Vax Technology, Inc. — PartnerFacts page ↗Form D/A · Feb 7, 2019 ↗Elucida Oncology, Inc. — PartnerFacts page ↗

Sources

Form D/A · Jul 18, 2019 ↗ (Jul 18, 2019)
X-Vax Technology, Inc. — PartnerFacts page ↗ (Jul 18, 2019)
Form D/A · Feb 7, 2019 ↗ (Feb 7, 2019)
Elucida Oncology, Inc. — PartnerFacts page ↗ (Aug 3, 2023)
Form D · Sep 14, 2018 ↗ (Sep 14, 2018)
Elicio Therapeutics, Inc. — PartnerFacts page ↗ (Nov 2, 2022)
Form D · Jun 5, 2018 ↗ (Jun 5, 2018)
Form D/A · Jul 20, 2017 ↗ (Jul 20, 2017)

Note · Oct 3, 2018 – Apr 15, 2019

Isaac Blech's role changed at X-Vax Technology, Inc.: executive officer, director → director

The Oct 3, 2018 filing lists Isaac Blech as executive officer, director; the Apr 15, 2019 Form D/A lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Oct 3, 2018 ↗Form D/A · Apr 15, 2019 ↗Isaac Blech — PartnerFacts page ↗X-Vax Technology, Inc. — PartnerFacts page ↗

Sources

Form D · Oct 3, 2018 ↗ (Oct 3, 2018)
Form D/A · Apr 15, 2019 ↗ (Apr 15, 2019)
Isaac Blech — PartnerFacts page ↗
X-Vax Technology, Inc. — PartnerFacts page ↗ (Jul 18, 2019)

Note · Feb 24, 2014 – Jul 18, 2019

5 offerings changed their target amount between filings

Offering amount changed between filings — X-Vax Technology, Inc. · Offering amount changed between filings — X-Vax Technology, Inc. · Offering amount changed between filings — X4 Pharmaceuticals, Inc. · Offering amount changed between filings — WaveGuide Corp · Offering amount changed between filings — SpendSmart Payments Co

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D/A (earlier) · May 31, 2019 ↗Form D/A (later) · Jul 18, 2019 ↗X-Vax Technology, Inc. — PartnerFacts page ↗Form D (earlier) · Oct 3, 2018 ↗

Sources

Form D/A (earlier) · May 31, 2019 ↗ (May 31, 2019)
Form D/A (later) · Jul 18, 2019 ↗ (Jul 18, 2019)
X-Vax Technology, Inc. — PartnerFacts page ↗ (Jul 18, 2019)
Form D (earlier) · Oct 3, 2018 ↗ (Oct 3, 2018)
Form D/A (later) · Apr 15, 2019 ↗ (Apr 15, 2019)
Form D (earlier) · Nov 15, 2017 ↗ (Nov 15, 2017)
Form D/A (later) · Sep 21, 2018 ↗ (Sep 21, 2018)
X4 Pharmaceuticals, Inc. — PartnerFacts page ↗ (Sep 21, 2018)

Note · Oct 3, 2018 – Apr 15, 2019

Minimum investment changed between filings — X-Vax Technology, Inc.

The Oct 3, 2018 filing lists a minimum of $25,000; the Apr 15, 2019 Form D/A lists $20,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Oct 3, 2018 ↗Form D/A (later) · Apr 15, 2019 ↗X-Vax Technology, Inc. — PartnerFacts page ↗

Sources

Form D (earlier) · Oct 3, 2018 ↗ (Oct 3, 2018)
Form D/A (later) · Apr 15, 2019 ↗ (Apr 15, 2019)
X-Vax Technology, Inc. — PartnerFacts page ↗ (Jul 18, 2019)

Note · Apr 28, 2015 – Jun 17, 2015

Minimum investment changed between filings — WaveGuide Corp

The Apr 28, 2015 filing lists a minimum of $50,000; the Jun 17, 2015 Form D/A lists $9,875.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Apr 28, 2015 ↗Form D/A (later) · Jun 17, 2015 ↗WaveGuide Corp — PartnerFacts page ↗

Sources

Form D (earlier) · Apr 28, 2015 ↗ (Apr 28, 2015)
Form D/A (later) · Jun 17, 2015 ↗ (Jun 17, 2015)
WaveGuide Corp — PartnerFacts page ↗ (Jul 30, 2026)

Note · May 22, 2014 – Mar 16, 2017

Reported revenue range changed between filings — Diffusion Pharmaceuticals Inc.

"$1 - $1,000,000" (May 22, 2014); then "Decline to Disclose" (Mar 16, 2017).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · May 22, 2014 ↗Form D · Mar 16, 2017 ↗Diffusion Pharmaceuticals Inc. — PartnerFacts page ↗

Sources

Form D · May 22, 2014 ↗ (May 22, 2014)
Form D · Mar 16, 2017 ↗ (Mar 16, 2017)
Diffusion Pharmaceuticals Inc. — PartnerFacts page ↗ (May 27, 2020)

Note · Sep 12, 2016 – Oct 3, 2018

Address moved from New York, NY to Jupiter, FL — X-Vax Technology, Inc.

The people listed on the Sep 12, 2016 filing give New York, NY; on the Oct 3, 2018 filing they give Jupiter, FL. The address now on file (601 Heritage Drive, Suite 138, Jupiter, FL) is a registered-agent or shared-office address used by 8 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Form D · Sep 12, 2016 ↗Form D · Oct 3, 2018 ↗X-Vax Technology, Inc. — PartnerFacts page ↗

Sources

Form D · Sep 12, 2016 ↗ (Sep 12, 2016)
Form D · Oct 3, 2018 ↗ (Oct 3, 2018)
X-Vax Technology, Inc. — PartnerFacts page ↗ (Jul 18, 2019)

Note · Jan 5, 2017 – Jan 2, 2018

Address moved from Baltimore, MD to Boston, MA — Centrexion Therapeutics Corp

The people listed on the Jan 5, 2017 filing give Baltimore, MD; on the Jan 2, 2018 filing they give Boston, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jan 5, 2017 ↗Form D · Jan 2, 2018 ↗Centrexion Therapeutics Corp — PartnerFacts page ↗

Sources

Form D · Jan 5, 2017 ↗ (Jan 5, 2017)
Form D · Jan 2, 2018 ↗ (Jan 2, 2018)
Centrexion Therapeutics Corp — PartnerFacts page ↗ (Jan 8, 2024)

Note · May 22, 2014 – Mar 16, 2017

Address moved from Los Angeles, CA to Charlottesville, VA — Diffusion Pharmaceuticals Inc.

The people listed on the May 22, 2014 filing give Los Angeles, CA; on the Mar 16, 2017 filing they give Charlottesville, VA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · May 22, 2014 ↗Form D · Mar 16, 2017 ↗Diffusion Pharmaceuticals Inc. — PartnerFacts page ↗

Sources

Form D · May 22, 2014 ↗ (May 22, 2014)
Form D · Mar 16, 2017 ↗ (Mar 16, 2017)
Diffusion Pharmaceuticals Inc. — PartnerFacts page ↗ (May 27, 2020)

Note · Feb 24, 2014 – Jul 18, 2019

Isaac Blech is listed with 10 different address states: IA, CA, MD, NC, NJ, MA, NY, PA, VA, FL

IA on 2 filings (Feb 24, 2014 to Mar 18, 2014); CA on 5 filings (May 22, 2014 to Feb 14, 2018); MD on 7 filings (Jul 21, 2014 to May 8, 2017); NC on 7 filings (Nov 6, 2014 to Sep 26, 2016); NJ on 2 filings (Nov 13, 2014 to Apr 9, 2015); MA on 11 filings (Apr 28, 2015 to Sep 21, 2018); NY on 10 filings (Jun 25, 2015 to Feb 7, 2019); PA on 1 filing (Oct 15, 2015); VA on 1 filing (Mar 16, 2017); FL on 5 filings (Oct 3, 2018 to Jul 18, 2019).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Feb 24, 2014 ↗Form D · May 22, 2014 ↗Form D · Jul 21, 2014 ↗Form D · Nov 6, 2014 ↗

Sources

What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. We compared the newest 50 of 75 filings (work cap); older filings are not covered here. As of Oct 24, 2026.

5. Money to insiders

37 of 56 offerings report sales commissions totalling $49,350,368; 2 report finder's fees totalling $3,601,999; 11 report proceeds to related persons totalling $5,372,848. (includes amounts the issuer reported as estimates)

Offering (latest filing)	Sales commissions	Finder's fees	To insiders	Paid to sell it	Source
Jul 18, 2019 D/A X-Vax Technology, Inc. File 021-322669	$5,646,346	$0	$0 The company has agreed to pay its CEO and COO a bonus equal to their accrued/unpaid salary, half of which is due upon a closing of $15 million in the offering and half upon a closing of $30 million (or at the closing of a subsequent financing).	Maxim Group LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Feb 7, 2019 D/A Elucida Oncology, Inc. File 021-293250	$2,875,960 (est.)	$0	$400,000 Upon a closing of $15 million in the aggregate, Mr. Edward Rosen, the Company's former CEO, is entitled to the receive up to $400,000 relating to various consulting fees and the reimbursement of expenses pursuant to the terms of his employment agreement.	Maxim Group LLC BrokerCheck CRD 12078 ↗	EDGAR ↗
Sep 21, 2018 D/A X4 Pharmaceuticals, Inc. File 021-298854	$2,373,224 (est.)	$0	$0	Maxim Group, LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Sep 14, 2018 D Elicio Therapeutics, Inc. File 021-321450	$525,000 (est.)	$0	$0	None no CRD number reported via Maxim Merchant Capital (CRD 120708 ↗)	EDGAR ↗
Aug 3, 2018 D Elicio Therapeutics, Inc. File 021-318453	$1,449,250 (est.)	$0	$0	None no CRD number reported via Maxim Merchant Capital (CRD 120708 ↗)	EDGAR ↗
Jun 5, 2018 D Elicio Therapeutics, Inc. File 021-313861	$299,000 (est.)	$0	$0	None no CRD number reported via Maxim Merchant Capital (CRD 120708 ↗)	EDGAR ↗
Feb 14, 2018 D Alveo Technologies Inc. File 021-305594	$3,148,142	$0	$0	Maxim Group LLC no CRD number reported	EDGAR ↗
Jan 2, 2018 D Centrexion Therapeutics Corp File 021-302145	$3,630,000 (est.)	$0	$0	Maxim Group LLC BrokerCheck CRD 120708 ↗ Leerink Partners LLC BrokerCheck CRD 39011 ↗	EDGAR ↗
Nov 28, 2017 D Adhera Therapeutics, Inc. File 021-299533	$0	$0	$0	none no CRD number reported	EDGAR ↗
Jul 20, 2017 D/A Nacuity Pharmaceuticals, Inc. File 021-289536	$922,700	$0	$0	Maxim Group LLC BrokerCheck CRD 120708 ↗ via Clifford Adam Teller (CRD 4631188 ↗)	EDGAR ↗
May 8, 2017 D Avalo Therapeutics, Inc. File 021-286257	$0	$0	$0	None listed on this filing	EDGAR ↗
Mar 16, 2017 D Diffusion Pharmaceuticals Inc. File 021-282760	$1,498,066 (est.)	$0	$0 A portion of the proceeds may be used for general corporate purposes, including to pay salaries of some related persons listed in Item 3.	Maxim Group LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Jan 5, 2017 D Centrexion Therapeutics Corp File 021-277676	$1,325,183	$0	$0 (est.)	N/A no CRD number reported via Maxim Group LLC (CRD 120708 ↗)	EDGAR ↗
Dec 15, 2016 D Aridis Pharmaceuticals, Inc. File 021-276429	$1,364,270	$0	$0	Maxim Merchant Capital, a division of Maxim Group LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Sep 26, 2016 D root9B Technologies, Inc. File 021-271315	$0	$0	$0	None listed on this filing	EDGAR ↗
Sep 16, 2016 D Avalo Therapeutics, Inc. File 021-270815	$0	$0	$0	None listed on this filing	EDGAR ↗
Sep 12, 2016 D X-Vax Technology, Inc. File 021-270414	$0	$0	$0	None no CRD number reported	EDGAR ↗
Sep 8, 2016 D Regenovation, Inc. File 021-270254	$0	$0	$0	None listed on this filing	EDGAR ↗
Aug 19, 2016 D Aridis Pharmaceuticals, Inc. File 021-269256	$1,521,624	$0	$0	Maxim Merchant Capital, a division of Maxim Group LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Jun 21, 2016 D Centrexion Therapeutics Corp File 021-265466	$669,810	$0	$0 (est.)	N/A no CRD number reported via Maxim Group LLC (CRD 120708 ↗)	EDGAR ↗
Jun 16, 2016 D InspireMD, Inc. File 021-265182	$0	$0	$0	None listed on this filing	EDGAR ↗
Apr 15, 2016 D Centrexion Therapeutics Corp File 021-261501	$318,300	$0	$0 (est.)	N/A no CRD number reported via Maxim Group LLC (CRD 120708 ↗)	EDGAR ↗
Apr 5, 2016 D Sapience Therapeutics, Inc. File 021-260695	$800,000	$0	$0	Maxim Group LLC BrokerCheck CRD 12078 ↗	EDGAR ↗
Mar 28, 2016 D InspireMD, Inc. File 021-260088	$48,760	$0	$0	Dawson James Securities, Inc. BrokerCheck CRD 130645 ↗	EDGAR ↗
Mar 14, 2016 D Centrexion Therapeutics Corp File 021-259218	$537,990	$0	$0 (est.)	N/A no CRD number reported via Maxim Group LLC (CRD 120708 ↗)	EDGAR ↗
Jan 11, 2016 D Sapience Therapeutics, Inc. File 021-254854	$0	$0	$0	None listed on this filing	EDGAR ↗
Dec 2, 2015 D root9B Technologies, Inc. File 021-252248	$0	$0	$0	None listed on this filing	EDGAR ↗
Oct 15, 2015 D Aevi Genomic Medicine, Inc. File 021-249442	$0	$0	$0	None listed on this filing	EDGAR ↗
Aug 28, 2015 D X4 Pharmaceuticals, Inc. File 021-246624	$3,000,000 (est.)	$0	$150,000 (est.)	Maxim Group, LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Aug 13, 2015 D root9B Technologies, Inc. File 021-245729	$0	$0	$0	None listed on this filing	EDGAR ↗
Jun 25, 2015 D CONTRAFECT Corp File 021-242461	$1,200,000	$0	$0 (est.)	Brookline Group, LLC BrokerCheck CRD 153587 ↗ M.M. Dillon & Co. LLC BrokerCheck CRD 19878 ↗	EDGAR ↗
Jun 17, 2015 D/A WaveGuide Corp File 021-238775	$2,700,000	$0	$1,051,500 (est.) estimate includes future salaries that have not been finally determined	Maxim Group LLC BrokerCheck CRD 120708 ↗ via Maxim Group LLC (CRD 120708 ↗)	EDGAR ↗
Apr 9, 2015 D Edge Therapeutics, Inc. File 021-237569	$0	$3,301,999	$0 A portion of the proceeds may be used to pay salaries of some related persons listed in Item 3.	Maxim Group, LLC BrokerCheck CRD 120708 ↗ Leerink Partners LLC BrokerCheck CRD 39011 ↗ Credit Suisse Securities (USA) LLC BrokerCheck CRD 816 ↗	EDGAR ↗
Mar 17, 2015 D root9B Technologies, Inc. File 021-236037	$0	$0	$0	None listed on this filing	EDGAR ↗
Feb 20, 2015 D root9B Technologies, Inc. File 021-234448	$0	$0	$0	None listed on this filing	EDGAR ↗
Dec 3, 2014 D/A root9B Technologies, Inc. File 021-227875	$0	$0	$0	None listed on this filing	EDGAR ↗
Nov 13, 2014 D Edge Therapeutics, Inc. File 021-228305	$595,881	$0	$0 A portion of the proceeds may be used to pay salaries of some related persons listed in Item 3.	Maxim Group LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Jul 21, 2014 D Avalo Therapeutics, Inc. File 021-221427	$0	$300,000 (est.)	$755,000	Trout Capital LLC BrokerCheck CRD 131489 ↗	EDGAR ↗
May 22, 2014 D Diffusion Pharmaceuticals Inc. File 021-217814	$2,477,850	$0	$300,000 (est.) Past due compensation for officers and directors.	Maxim Group LLC BrokerCheck CRD 120708 ↗ via Kareem Ali (CRD 4369152 ↗)	EDGAR ↗
Mar 18, 2014 D/A SpendSmart Payments Co File 021-212399	$1,221,718	$0	$0	Maxim Group LLC BrokerCheck CRD 12078 ↗	EDGAR ↗
Mar 12, 2014 D CONTRAFECT Corp File 021-213471	$0	$0	$0 (est.)	None listed on this filing	EDGAR ↗
Dec 3, 2013 D/A Centrexion Therapeutics Corp File 021-206864	$1,178,311	$0	$416,388 (est.) To pay back salary for executive officers: (1) Kerrie L. Brady, (2) James N. Campbell and (3) Jeffrey B. Kindler.	N/A no CRD number reported via Maxim Group LLC (CRD 120708 ↗)	EDGAR ↗
Dec 3, 2013 D Centrexion Therapeutics Corp File 021-207282	$0	$0	$0 (est.)	None listed on this filing	EDGAR ↗
Nov 5, 2013 D SpendSmart Payments Co File 021-205824	$0	$0	$0	None listed on this filing	EDGAR ↗
Sep 6, 2013 D Avalo Therapeutics, Inc. File 021-202469	$555,000 (est.)	$0	$0 (est.)	Maxim Group, LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Jul 26, 2013 D SpendSmart Payments Co File 021-200294	$89,442	$0	$0	Maxim Group LLC BrokerCheck CRD 12078 ↗	EDGAR ↗
Jul 2, 2013 D/A root9B Technologies, Inc. File 021-189758	$75,000	$0	$0	American Capital Partners, LLC BrokerCheck CRD 119249 ↗	EDGAR ↗
Mar 25, 2013 D Edge Therapeutics, Inc. File 021-193853	$600,608	$0	$0 A portion of the proceeds may be used to pay salaries of some related persons listed in Item 3.	Maxim Group LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Jan 8, 2013 D root9B Technologies, Inc. File 021-189757	$75,000	$0	$0	American Capital Partners, LLC BrokerCheck CRD 119249 ↗	EDGAR ↗
Dec 14, 2012 D SpendSmart Payments Co File 021-188403	$548,799	$0	$60,000 Amount is for salaries and bonus for named executive officers in the normal course of business.	Maxim Group LLC BrokerCheck CRD 12078 ↗	EDGAR ↗
Aug 1, 2012 D/A SpendSmart Payments Co File 021-173928	$872,243	$0	$550,000 Amount is for salaries and bonus for named executive officers in the normal course of business.	Maxim Group LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Jul 2, 2012 D Aevi Genomic Medicine, Inc. File 021-180622	$952,919 (est.)	$0	$555,000 (est.) proceeds to be used for general corporate purposes including payment of salaries	Maxim Group LLC BrokerCheck CRD 281147 ↗	EDGAR ↗
Apr 4, 2012 D Avalo Therapeutics, Inc. File 021-176170	$2,207,919 (est.)	$0	$1,074,960 (est.)	Maxim Group LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Dec 2, 2011 D/A SpendSmart Payments Co File 021-167752	$470,850	$0	$60,000 Amount is for salaries for named executive officers in the normal course of business.	Maxim Group LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Sep 15, 2011 D CONTRAFECT Corp File 021-165957	$875,203	$0	$0	Maxim Group LLC BrokerCheck CRD 120708 ↗	EDGAR ↗
Jun 6, 2011 D SpendSmart Payments Co File 021-160795	$700,000	$0	$0	Maxim Group LLC BrokerCheck CRD 120708 ↗ Equity Source Partners, LLC no CRD number reported	EDGAR ↗

How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 20

Every issuer that named Isaac Blech on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

X-Vax Technology, Inc.

Jupiter, FL · Sep 12, 2016 → Jul 18, 2019 · 6 filings

Jul 18, 2019 · D/A · $56,463,455 sold of $58,000,000 · 306 investors · min. $20,000 · role: Director (Vice Chairman of the Board of Directors) EDGAR ↗
May 31, 2019 · D/A · $46,682,455 sold of $55,000,000 · 269 investors · min. $20,000 · role: Director (Vice Chairman of the Board of Directors) EDGAR ↗
Apr 17, 2019 · D/A · $42,187,450 sold of $55,000,000 · 242 investors · min. $20,000 · role: Director (Vice Chairman of the Board of Directors) EDGAR ↗
Apr 15, 2019 · D/A · $39,267,450 sold of $55,000,000 · 230 investors · min. $20,000 · role: Director (Vice Chairman of the Board of Directors) EDGAR ↗
Oct 3, 2018 · D · $6,550,000 sold of $30,000,000 · 9 investors · min. $25,000 · role: Executive Officer, Director (Vice Chairman of the Board of Directors) EDGAR ↗
Sep 12, 2016 · D · $100,000 sold of $1,000,000 · 1 investors · min. $25,000 · role: Executive Officer, Director (Vice Chairman) EDGAR ↗

Raised $56.5M from 306 investors (97% of the $58M target) as of the latest filing. Isaac is listed as director, executive officer on 6 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Elucida Oncology, Inc.

Monmouth Junction, NJ · Aug 22, 2017 → Feb 7, 2019 · 3 filings

Feb 7, 2019 · D/A · $28,759,605 sold of $30,000,000 · 175 investors · min. $25,000 · role: Director EDGAR ↗
Jan 3, 2019 · D/A · $28,094,604 sold of $30,000,000 · 170 investors · min. $25,000 · role: Director EDGAR ↗
Aug 22, 2017 · D · $10,859,249 sold of $30,000,000 · 94 investors · min. $25,000 · role: Director EDGAR ↗

Raised $35M from 328 investors (100% of the $30M target) as of the latest filing. Isaac is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗

Sources

Pharmaceuticals · group: X4 Pharmaceuticals

X4 Pharmaceuticals, Inc.

Cambridge, MA · Aug 28, 2015 → Sep 21, 2018 · 3 filings

Sep 21, 2018 · D/A · $34,999,150 sold of $34,999,150 · 214 investors · min. $50,000 · role: Director EDGAR ↗
Nov 15, 2017 · D · $25,838,812 sold of $30,000,000 · 213 investors · min. $50,000 · role: Director EDGAR ↗
Aug 28, 2015 · D · $37,499,999 sold of $37,500,000 · 220 investors · min. $24,579 · role: Director EDGAR ↗

Raised $37.5M from 220 investors (100% of the $35M target) as of the latest filing. Isaac is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology · group: Elicio Therapeutics

Elicio Therapeutics, Inc.

Boston, MA · Jun 5, 2018 → Sep 14, 2018 · 3 filings

Sep 14, 2018 · D · $25,817,848 sold of $36,235,347 · 137 investors · min. No minimum reported · role: Director EDGAR ↗
Aug 3, 2018 · D · $14,492,501 sold of $14,492,501 · 115 investors · min. No minimum reported · role: Director EDGAR ↗
Jun 5, 2018 · D · $2,990,000 sold of $3,000,000 · 27 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $25.8M from 137 investors (71% of the $36.2M target) as of the latest filing. Isaac is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗

Sources

Biotechnology

Alveo Technologies Inc.

Alameda, CA · Feb 14, 2018

Feb 14, 2018 · D · $47,605,531 sold of $47,605,531 · 248 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $47.6M from 248 investors (100% of the $47.6M target) as of the latest filing. Isaac is listed as director.

Latest filing on EDGAR ↗

Sources

Biotechnology

Centrexion Therapeutics Corp

Boston, MA · Nov 22, 2013 → Jan 2, 2018 · 8 filings

Jan 2, 2018 · D · $69,566,532 sold of $69,566,532 · 67 investors · min. No minimum reported · role: Director EDGAR ↗
Jan 5, 2017 · D · $16,564,789 sold of $16,564,789 · 14 investors · min. $25,000 · role: Director EDGAR ↗
Jun 21, 2016 · D · $11,163,500 sold of Indefinite · 61 investors · min. No minimum reported · role: Director EDGAR ↗
Apr 15, 2016 · D · $6,905,000 sold of Indefinite · 21 investors · min. No minimum reported · role: Director EDGAR ↗
Mar 14, 2016 · D · $10,516,500 sold of Indefinite · 25 investors · min. No minimum reported · role: Director EDGAR ↗
Dec 3, 2013 · D/A · $14,728,886 sold of $35,000,000 · 98 investors · min. No minimum reported · role: Director EDGAR ↗
Dec 3, 2013 · D · $8,750,000 sold of $8,750,000 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
Nov 22, 2013 · D · $14,728,886 sold of $35,000,000 · 98 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $69.6M from 124 investors (100% of the $69.6M target) as of the latest filing. Isaac is listed as director on 8 filings for this deal.

Latest filing on EDGAR ↗

Sources

Biotechnology

Adhera Therapeutics, Inc.

Wake Forest, NC · Nov 28, 2017

Nov 28, 2017 · D · $500,000 sold of $500,000 · 1 investors · min. $500,000 · role: Director EDGAR ↗

Raised $44M from 97 investors (100% of the $500K target) as of the latest filing. Isaac is listed as director.

Latest filing on EDGAR ↗

Sources

Biotechnology

Nacuity Pharmaceuticals, Inc.

Fort Worth, TX · Jun 27, 2017 → Jul 20, 2017 · 2 filings

Jul 20, 2017 · D/A · $9,227,000 sold of $10,000,000 · 125 investors · min. $25,000 · role: Director EDGAR ↗
Jun 27, 2017 · D · $7,310,000 sold of $10,000,000 · 102 investors · min. $25,000 · role: Director EDGAR ↗

Raised $11.6M from 144 investors (100% of the $10M target) as of the latest filing. Isaac is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗

Sources

Biotechnology

Avalo Therapeutics, Inc.

Rockville, MD · Apr 4, 2012 → May 8, 2017 · 5 filings

May 8, 2017 · D · $5,000,000 sold of $5,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
Sep 16, 2016 · D · $1,000,000 sold of $15,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
Jul 21, 2014 · D · $16,259,016 sold of $33,259,016 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
Sep 6, 2013 · D · $6,805,883 sold of $10,000,000 · 146 investors · min. $5,000 · role: Director EDGAR ↗
Apr 4, 2012 · D · $22,137,301 sold of $22,500,000 · 156 investors · min. $24,000 · role: Director EDGAR ↗

Raised $130.6M from 156 investors (100% of the $5M target) as of the latest filing. Isaac is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗

Sources

Pharmaceuticals · group: Diffusion Pharmaceuticals

Diffusion Pharmaceuticals Inc.

Charlottesville, VA · May 22, 2014 → Mar 16, 2017 · 2 filings

Mar 16, 2017 · D · $15,830,661 sold of $25,000,000 · 145 investors · min. No minimum reported · role: Director EDGAR ↗
May 22, 2014 · D · $24,778,500 sold of $50,000,000 · 146 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $85.7M from 181 investors (100% of the $25M target) as of the latest filing. Isaac is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals

Aridis Pharmaceuticals, Inc.

Los Gatos, CA · Aug 19, 2016 → Dec 15, 2016 · 2 filings

Dec 15, 2016 · D · $13,642,707 sold of $25,000,000 · 14 investors · min. $25,000 · role: Director (Vice Chairman) EDGAR ↗
Aug 19, 2016 · D · $15,216,241 sold of $40,000,000 · 133 investors · min. $50,000 · role: Director (Vice Chairman) EDGAR ↗

Raised $15.2M from 133 investors (61% of the $25M target) as of the latest filing. Isaac is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Business Services

root9B Technologies, Inc.

Charlotte, NC · Jan 8, 2013 → Sep 26, 2016 · 12 filings

Sep 26, 2016 · D · $3,636,000 sold of $10,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
Dec 2, 2015 · D · $845,750 sold of $7,700,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
Aug 13, 2015 · D · $0 sold of $0 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
Mar 17, 2015 · D · $4,055,498 sold of $4,055,498 · 17 investors · min. $50,000 · role: Director EDGAR ↗
Feb 20, 2015 · D · $7,353,753 sold of $7,353,753 · 1 investors · min. $50,000 · role: Director EDGAR ↗
Dec 3, 2014 · D/A · $1,800,000 sold of $2,000,000 · 7 investors · min. $50,000 · role: Director EDGAR ↗
Nov 6, 2014 · D · $1,250,000 sold of $2,000,000 · 5 investors · min. $50,000 · role: Director EDGAR ↗
Jul 2, 2013 · D/A · $750,000 sold of $1,000,000 · 6 investors · min. $25,000 · role: Director EDGAR ↗
Mar 7, 2013 · D/A · $13,126,000 sold of $15,000,000 · 118 investors · min. $25,000 · role: Director EDGAR ↗
Jan 31, 2013 · D/A · $11,100,100 sold of $15,000,000 · 99 investors · min. $25,000 · role: Director EDGAR ↗
Jan 8, 2013 · D · $7,046,000 sold of $15,000,000 · 38 investors · min. $25,000 · role: Director EDGAR ↗
Jan 8, 2013 · D · $750,000 sold of $1,000,000 · 7 investors · min. $50,000 · role: Director EDGAR ↗

Raised $13.1M from 118 investors (100% of the $10M target) as of the latest filing. Isaac is listed as director on 12 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Business Services / 506(b) (965 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Regenovation, Inc.

New York, NY · Sep 8, 2016

Sep 8, 2016 · D · $1,375,500 sold of $4,000,000 · 10 investors · min. $50,000 · role: Director EDGAR ↗

Raised $1.38M from 10 investors (34% of the $4M target) as of the latest filing. Isaac is listed as director.

Latest filing on EDGAR ↗

Sources

Biotechnology

InspireMD, Inc.

Miami, FL · Mar 28, 2016 → Jun 16, 2016 · 2 filings

Jun 16, 2016 · D · $182,399 sold of $182,399 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
Mar 28, 2016 · D · $609,500 sold of $609,500 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $42.2M from 24 investors (100% of the $182K target) as of the latest filing. Isaac is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗

Sources

Biotechnology

Sapience Therapeutics, Inc.

Harrison, NY · Jan 11, 2016 → Apr 5, 2016 · 2 filings

Apr 5, 2016 · D · $0 sold of $22,500,000 · 0 investors · min. $50,000 · role: Director EDGAR ↗
Jan 11, 2016 · D · $300,000 sold of $1,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $8.01M from 83 investors (36% of the $22.5M target) as of the latest filing. Isaac is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗

Sources

Biotechnology

Aevi Genomic Medicine, Inc.

Wayne, PA · Jul 2, 2012 → Oct 15, 2015 · 2 filings

Oct 15, 2015 · D · $3,200,000 sold of $3,200,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
Jul 2, 2012 · D · $9,529,196 sold of $9,529,382 · 88 investors · min. $15,000 · role: Director EDGAR ↗

Raised $28M from 88 investors (100% of the $3.2M target) as of the latest filing. Isaac is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗

Sources

Biotechnology

CONTRAFECT Corp

Yonkers, NY · Sep 15, 2011 → Jun 25, 2015 · 3 filings

Jun 25, 2015 · D · $20,000,000 sold of $20,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
Mar 12, 2014 · D · $0 sold of Indefinite · 1 investors · min. No minimum reported · role: Director EDGAR ↗
Sep 15, 2011 · D · $12,502,905 sold of $25,000,000 · 125 investors · min. $25,000 · role: Director EDGAR ↗

Raised $20M from 125 investors (100% of the $20M target) as of the latest filing. Isaac is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(c) (163 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care

WaveGuide Corp

Waltham, MA · Apr 28, 2015 → Jun 17, 2015 · 2 filings

Jun 17, 2015 · D/A · $27,000,000 sold of $27,000,000 · 197 investors · min. $9,875 · role: Director EDGAR ↗
Apr 28, 2015 · D · $13,920,380 sold of $20,000,000 · 148 investors · min. $50,000 · role: Director EDGAR ↗

Raised $27M from 197 investors (100% of the $27M target) as of the latest filing. Isaac is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals

Edge Therapeutics, Inc.

Berkeley Heights, NJ · Mar 25, 2013 → Apr 9, 2015 · 3 filings

Apr 9, 2015 · D · $55,999,978 sold of $56,000,000 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
Nov 13, 2014 · D · $7,937,236 sold of $25,000,000 · 104 investors · min. $10,000 · role: Director EDGAR ↗
Mar 25, 2013 · D · $6,673,405 sold of $20,000,000 · 52 investors · min. $50,000 · role: Director EDGAR ↗

Raised $56M from 104 investors (100% of the $56M target) as of the latest filing. Isaac is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other

SpendSmart Payments Co

Des Moines, IA · Jun 6, 2011 → Mar 18, 2014 · 12 filings

Mar 18, 2014 · D/A · $12,217,186 sold of $15,000,000 · 147 investors · min. $50,000 · role: Director EDGAR ↗
Feb 24, 2014 · D · $6,440,729 sold of $10,000,000 · 86 investors · min. $50,000 · role: Director EDGAR ↗
Nov 5, 2013 · D · $500,000 sold of $1,000,000 · 2 investors · min. $50,000 · role: Director EDGAR ↗
Jul 26, 2013 · D · $1,490,715 sold of $1,490,715 · 117 investors · min. $100 · role: Director EDGAR ↗
Dec 14, 2012 · D · $5,487,990 sold of $8,500,000 · 62 investors · min. $25,000 · role: Director EDGAR ↗
Aug 1, 2012 · D/A · $10,146,431 sold of $10,146,431 · 97 investors · min. $5,000 · role: Director EDGAR ↗
Jun 29, 2012 · D/A · $9,756,431 sold of $10,000,000 · 92 investors · min. $5,000 · role: Director EDGAR ↗
Jun 5, 2012 · D/A · $5,941,431 sold of $10,000,000 · 63 investors · min. $5,000 · role: Director EDGAR ↗
Feb 24, 2012 · D · $229,000 sold of $10,000,000 · 6 investors · min. $5,000 · role: Director EDGAR ↗
Dec 2, 2011 · D/A · $4,708,500 sold of $10,000,000 · 39 investors · min. $5,000 · role: Director EDGAR ↗
Oct 25, 2011 · D · $2,542,500 sold of $10,000,000 · 17 investors · min. $5,000 · role: Director EDGAR ↗
Jun 6, 2011 · D · $7,000,000 sold of Indefinite · 1 investors · min. $1,000,000 · role: Director EDGAR ↗

Raised $12.2M from 147 investors (81% of the $15M target) as of the latest filing. Isaac is listed as director on 12 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Isaac 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

No photo found yet (own website and image search run after this page is viewed)

Person

Cary Sucoff

Director · 28 shared filings (4 issuers) · also on 1 other issuer

Cary Sucoff is on 5 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Patrick Kolenik

Director · 22 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Sol J Barer

Director · 19 shared filings (7 issuers) · also on 2 other issuers

Sol J Barer is on 9 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Joseph Grano, Jr.

Director, Executive Officer · 13 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

John Catsimatidis

Director · 13 shared filings (2 issuers)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Gregory Morris

Director · 12 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Kevin Carnahan

Director · 12 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Seymour Siegel

Director · 12 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Wesley Clark

Director · 11 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Harvey Pitt

Director · 11 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Michael Robert McCoy

Executive Officer, Director · 11 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Mark Elliott

Executive Officer, Director · 9 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Joseph Proto

Director · 9 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Jonathan Drew Shultz

Executive Officer · 8 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

James N. Campbell

Executive Officer, Director · 8 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Arnold L. Oronsky

Director · 8 shared filings (1 issuer) · also on 14 other issuers

Arnold L. Oronsky is on 15 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Kerrie L. Brady

Executive Officer · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Jeffrey B. Kindler

Executive Officer · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Eugene Bauer

Director · 7 shared filings (2 issuers) · also on 9 other issuers

Eugene Bauer is on 11 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Rob DeSantis

Director · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Brian King

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Kenneth Smith

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

ROGER J. POMERANTZ

Director · 6 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

William A. Haseltine

Director · 6 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Graeme Booth

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

John Galt

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Larry Brumfield

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

William Hernandez-Ellsworth

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Ka Cheong Christopher Leong

Director · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Daniel Wachtler

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Shengda Zan

Director · 5 shared filings (2 issuers)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Matthew Stober

Director · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Roger Jeffs

Director · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Ian T. Clark

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Ulf Wiinberg

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Gregg Beloff

Executive Officer · 5 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Robert R. Ruffolo

Director · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Brian D. Finn

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Jesse Itzler

Director · 4 shared filings (1 issuer)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

James Loughlin

Director · 4 shared filings (2 issuers)

Listed on the same filings as Isaac Blech. Their page shows their other deals.

The team behind the deals

Sponsor group

X4 Pharmaceuticals

2 issuers · 16 filings · $120M reported sold · 2010–2025

XP X4 Pharmaceuticals, Inc Biotechnology · $85M sold · 2010
XP X4 Pharmaceuticals, Inc. Pharmaceuticals · $37.5M sold · 2015 · listed

One team, 2 deal companies. Isaac Blech is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Isaac Blech.

Sponsor group

Elicio Therapeutics

2 issuers · 21 filings · $28M reported sold · 2012–2024

ET Elicio Therapeutics, Inc. Biotechnology · $15.4M sold · 2015
ET Elicio Therapeutics, Inc. Biotechnology · $25.8M sold · 2012 · listed

One team, 2 deal companies. Isaac Blech is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Isaac Blech.

Sponsor group

Diffusion Pharmaceuticals

2 issuers · 16 filings · $3.15M reported sold · 2009–2020

DP Diffusion Pharmaceuticals Inc. Pharmaceuticals · $85.7M sold · 2011 · listed
DP DIFFUSION PHARMACEUTICALS LLC Pharmaceuticals · $5M sold · 2009

One team, 2 deal companies. Isaac Blech is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Isaac Blech.

Same business address

51 other issuers file from the same address (first 50 shown)

SGP - RSTRS Davidson, LLC Charlotte, NC · 2026
PL - 2026 PREDEVELOPMENT, LLC Charlotte, NC · 2026
Aline Technologies, Inc. Berkeley Heights, NJ · 2025
Park Overlook Equities Fund LP Harrison, NY · 2017
SGP - Mobile Homes II, LLC Charlotte, NC · 2026
SGP - Cary, LLC Charlotte, NC · 2026
Seminal Food & Nutrition Investments SPV VIII, L.P. Wayne, PA · 2026
SGP - BB Financial, LLC Charlotte, NC · 2026
SGP - FBAI, LLC Charlotte, NC · 2026
Stoka Global, LP Harrison, NY · 2022
FRESHFORD PARTNERS, LP Harrison, NY · 2009
Healthy Humans Tea LLC Wayne, PA · 2022
Plank Road Financial Partners II, LLC Charlotte, NC · 2026
Seminal Capital Investments SPV IV, L.P. Wayne, PA · 2026
MCM - Noble Bakery, LLC Charlotte, NC · 2025
MCM - Financial IX, LLC Charlotte, NC · 2025
MCM - WATAUGA, LLC Charlotte, NC · 2025
MCM - BIG BEN REALTY, LLC Charlotte, NC · 2025
MCM - PALMETTO, LLC Charlotte, NC · 2025
Palmetto Street Realty, LLC Charlotte, NC · 2025
MCM - SHORT PUMP, LLC Charlotte, NC · 2025
PL - 2025 Predevelopment, LLC Charlotte, NC · 2025
Udeego, Inc. Jupiter, FL · 2021
Cyclacel Pharmaceuticals, Inc. Berkeley Heights, NJ · 2010
MCM - Nags Head, LLC Charlotte, NC · 2025
NIGHTHAWK MOMENTUM FUND, LLC Jupiter, FL · 2023
CFA FINANCIAL PARTNERS I, LLC Charlotte, NC · 2024
MCM - Sandhills Gateway, LLC Charlotte, NC · 2024
MCM - MOBILE HOMES I, LLC Charlotte, NC · 2024
MCM - NET LEASE I, LLC Charlotte, NC · 2024
MCM - WAGS Ramseur, LLC Charlotte, NC · 2024
MCM - MONTFORD, LLC Charlotte, NC · 2024
MCM - RSTRS BALLANTYNE, LLC Charlotte, NC · 2024
MCM - WAGS Lewisville, LLC Charlotte, NC · 2024
MCM - Gervais Street, LLC Charlotte, NC · 2024
PL - 2024 Predevelopment, LLC Charlotte, NC · 2024
MCM - Financial VIII, LLC Charlotte, NC · 2024
MECHONIT I, LLC Harrison, NY · 2019
PL Investment, LLC Waltham, MA · 2015
PL Investment 2023, LLC Waltham, MA · 2024
Plank Road Financial Partners, LLC Charlotte, NC · 2024
MCM - CPH, LLC Charlotte, NC · 2023
MCM - WAGS III, LLC Charlotte, NC · 2023
MCM - BATTLEGROUND, LLC Charlotte, NC · 2023
MCM - Baltimore, LLC Charlotte, NC · 2023
MCM - Financial VII, LLC Charlotte, NC · 2023
Mariner GreyArc Equity Fund, L.P. Harrison, NY · 2022
ZIELBIO, INC. Charlottesville, VA · 2011
Baukunst Fund I, L.P. Cambridge, MA · 2022
BetterLesson, Inc. Cambridge, MA · 2011

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 20 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Isaac Blech by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 20 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Isaac Blech is listed on: none on file. No website or social profile named in Alveo Technologies Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #195,521 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Alameda, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Business registries

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Isaac Blech appears on a new Form D, or when a court case or SEC action is matched to them. See plans →

Isaac Blech

The short version

What the community is saying

Key records

1. Lawsuits

2. Regulatory actions

3. Bankruptcies

4. Differences between public sources

4 regulator actions name the subject or team members

5 bankruptcy cases name the subject or team members

5 court cases name Isaac Blech — 4 as defendant

Isaac Blech appears on 3 deals that stopped filing before reaching their target

Paid seller listed without a CRD number: Maxim Group LLC — Alveo Technologies Inc.

7 Form Ds were filed more than 15 days after the first sale

24 offerings have no amendment in the last 12 months and may still be open

Isaac Blech's role changed at X-Vax Technology, Inc.: executive officer, director → director

5 offerings changed their target amount between filings

Minimum investment changed between filings — X-Vax Technology, Inc.

Minimum investment changed between filings — WaveGuide Corp

Reported revenue range changed between filings — Diffusion Pharmaceuticals Inc.

Address moved from New York, NY to Jupiter, FL — X-Vax Technology, Inc.

Address moved from Baltimore, MD to Boston, MA — Centrexion Therapeutics Corp

Address moved from Los Angeles, CA to Charlottesville, VA — Diffusion Pharmaceuticals Inc.

Isaac Blech is listed with 10 different address states: IA, CA, MD, NC, NJ, MA, NY, PA, VA, FL

5. Money to insiders

Deals 20

People around Isaac 40

The team behind the deals

51 other issuers file from the same address (first 50 shown)

Registrations and other filings

Business registration (state registry / Secretary of State)

Adviser registration (Form ADV)

Other offering types (Regulation A and Regulation Crowdfunding)

Public profiles and social

Look further

Social and web

Courts

Securities regulators

Business registries

Change history

Request a correction

Add a response

Monitor this person